CHAMPIONS ONCOLOGY INC
For the period ended Aug 27, 2024. Filed Aug 27, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Aug 27, 2024 · Filed Aug 27, 2024
Contents
Summary Compensation Table
The following table sets forth information regarding the total compensation paid or earned by the named executive officers as compensation for their services in all capacities during the fiscal years ended April 30, 2024 and 2023.
| Name and PrincipalPosition | Year | BaseSalary($) | Bonus($) | StockAwards ($) | OptionAwards ($)(1) | All OtherCompensation | Total ($) |
|---|---|---|---|---|---|---|---|
| Ronnie Morris | 2024 | 400,000 | — | — | — | — | 400,000 |
| Chief Executive Officer | 2023 | 400,000 | 200,000 | — | — | — | 600,000 |
| David Miller | 2024 | 260,000 | — | — | — | — | 260,000 |
| Chief Financial Officer | 2023 | 260,000 | 25,000 | — | 9,303 | — | 294,303 |
| Brady Davis | 2024 | 425,000 | 75,000 | — | 846,210 | — | 1,346,210 |
| President | 2023 | — | — | — | — | — | — |
(1)The amounts shown in the “Option Awards” column reflect the grant date value of the stock option awards computed in accordance with Financial Accounting Standards Board ASC Topic 718. For a discussion of valuation assumptions, see note 8 to the financial statements in the Company's Form 10-K filed on July 19, 2024. While these amounts are deductible for federal income tax purposes, for financial statement purposes these amounts are charged to additional paid-in capital.
The Compensation Committee has the right to change and increase the compensation of executive officers at any time.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.